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Unresolved infection by gram-negative bacteria can result in the potentially lethal condition known as
endotoxic shock, whereby uncontrolled inflammation can lead to multiple organ failure and death of the
infected host. Previous results have demonstrated that animals deficient in class A scavenger receptor
(SRA), a trafficking receptor for bacteria and bacterium-derived molecules, are more susceptible to
endotoxic shock. This has been proposed to be a result of impaired SRA-dependent phagocytic clearance
of bacteria resulting in stronger proinflammatory stimuli. In this report, we test the hypothesis that there
is an obligate reciprocal relationship between SRA-mediated phagocytosis of bacteria and susceptibility to
endotoxic shock. Here, we demonstrate that both SRA-dependent and -independent gram-negative bacte-
rial strains elicit SRA-dependent increased cytokine production in vitro and in vivo and increased
susceptibility to endotoxic shock in SRA-deficient mice. This is the first evidence showing that SRA-
mediated clearance of LPS is functionally distinct from the role of SRA in bacterial phagocytosis and is
a formal demonstration that the SRA-dependent cytokine responses and the resultant endotoxic shock are
not coupled to SRA-mediated clearance of bacteria.
Class A scavenger receptor (SRA) is a member of the scav-
enger receptor family that has a broad specificity for polyan-
ionic ligands. In the context of innate immunity to bacterial
pathogens, SRA binds a variety of bacterial cell wall compo-
nents and functions as a phagocytic receptor for a variety of
gram-negative and gram-positive bacteria, although the depen-
dence for SRA-mediated phagocytic recognition varies widely
for different species of bacteria and even varies among differ-
ent strains of the same bacterial species (13, 14, 18, 19). Ad-
ditionally, SRA functions as an endocytic receptor for soluble
bacterial cell wall ligands, including lipopolysaccharide (LPS)
from gram-negative bacteria (6, 7, 14, 20). The ability of SRA
to bind LPS via recognition of the lipid A molecule is charac-
terized to be important for in vivo clearance of LPS and results
in an attenuation of the inflammatory response to endotoxin
(4, 7, 8, 16, 18). Thus, SRA functions as a trafficking receptor
and facilitates both the endocytic clearance of bacterial li-
gands, like LPS, as well as phagocytic uptake of many bacteria
(10, 14, 19). However, in the context of infection by gram-
negative bacteria, the role of SRA-mediated phagocytic uptake
of bacteria in modulating LPS-driven inflammatory responses
has previously never been tested directly.
SRA deficiency in mice causes two major impairments in
the innate immune response. SRA knockout (SRA/) mice
are more susceptible to bacterial infections due to impaired
phagocytosis of bacteria (10, 18, 19). Additionally, SRA/
mice exhibit increased susceptibility to endotoxic shock (8,
16). These two observations have been proposed to be di-
rectly related, with the decreased phagocytic clearance of
bacteria in the absence of SRA leading to exacerbated ac-
tivation of TLR4 and resulting in hyperinflammation. In-
creased susceptibility to lethal endotoxic shock in SRA/
mice can be recapitulated with purified LPS and is at least
partially mediated by increased tumor necrosis factor alpha
(TNF-) production in these animals since TNF--neutral-
izing antibodies can abrogate this phenotype (8). However,
the specific relationship between the roles of SRA as a
phagocytic receptor for bacteria and an endocytic receptor
for LPS is poorly understood, nor is it known whether there
is an obligate functional relationship between the role of
SRA as a phagocytic receptor for bacteria and the conse-
quential host inflammatory response.
In this work, we use two approaches to demonstrate that the
role of SRA in limiting inflammatory responses to LPS is a
discrete process from phagocytosis of infecting bacteria. First,
we show that SRA/ cells, which are fully competent at
phagocytic clearance of bacteria, display the same enhanced
cytokine responses to gram-negative bacteria as those observed
in SRA/ cells. Second, using gram-negative bacteria that are
not phagocytosed via SRA, we show that these “SRA-indepen-
dent” bacteria still elicit increased inflammation in vitro and in
vivo in SRA/ cells and mice. Furthermore, SRA-indepen-
dent bacteria still cause increased susceptibility to endotoxic
shock in SRA/ mice. These data provide a new understand-
ing of how the role of SRA in endotoxin resistance is not
dependent on its function in phagocytosis of bacteria. This
report provides a new perspective on SRA function in the
innate immune response and on how this multifunctional re-
ceptor modulates two distinct pathways during infection by
gram-negative bacteria.
MATERIALS AND METHODS
Mice. C57BL/6 wild-type (WT) mice were obtained from The Jackson Labo-
ratory (Bar Harbor, ME). SRA/ mice (C57BL/6 background) were a generous
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gift of T. Kodama (Tokyo University) and M. W. Freeman (Massachusetts
General Hospital) (11, 17). TLR4/ and MyD88/ mice were generated by
Adachi et al. (1). Other mice were generated and screened as previously de-
scribed (2).
Materials. LPS was purchased from Sigma Aldrich (St. Louis, MO). DuoSet
enzyme-linked immunosorbent assay (ELISA) kits for mouse interleukin-6
(IL-6) and TNF- were purchased from R&D Systems (Minneapolis, MN).
F4/80 antibody was purchased from eBiosciences (San Diego, CA).
Cells. The bone marrow-derived dendritic cell (BMDC) culture protocol
used is a modification of that of Inaba et al. (9) as previously described (2).
Escherichia coli DH5 bacteria were transfected with the pTrcHis plasmid
(Invitrogen, Carlsbad, CA) to confer ampicillin resistance. E. coli K-12
(chloramphenicol-resistant) bacteria were a gift from Deb Hogan (Dart-
mouth), and Pseudomonas aeruginosa PA14 bacteria were a gift from George
O’Toole (Dartmouth).
Cytokine assays. For in vitro studies, dendritic cells (DCs) were harvested and
washed, and 5  105 cells were added to each well of a 48-well tissue culture
plate. A total of 100 ng/ml of LPS (Sigma Aldrich) or 5  105 of the indicated
bacteria were added to treated wells in 400 l total volume of Hanks balanced
salt solution (HBSS). DCs and bacteria were coincubated for 6 h at 37°C.
Supernatants were collected for cytokine analysis. For in vivo studies, mice were
injected intraperitoneally (i.p.) with either 1  109 CFU of the indicated E. coli
strains or 5  107 CFU of P. aeruginosa bacteria. After 3 h, mice were sacrificed.
Blood serum samples were collected by cardiac puncture. Samples were centri-
fuged at maximum speed on a tabletop microcentrifuge to collect serum samples.
Peritoneal cytokine samples were collected by lavage using 3 ml of HBSS.
Samples were centrifuged and supernatants collected. Serum and supernatant
samples were analyzed by ELISA.
Gentamicin protection assays. Phagocytosis of live E. coli or P. aeruginosa
bacteria was performed as a modified version of previously described protocols
(3, 5). Overnight cultures of E. coli or P. aeruginosa were washed twice in 1 ml
serum-free HBSS and centrifuged at 12,000 rpm. The bacterial pellets were
resuspended in 10 ml HBSS, and the bacterial concentration was determined by
spectrophotometric absorbance at 600 nM. A total of 2  105 BMDCs from the
various mouse genotypes described were incubated with bacteria at a multiplicity
of infection of 10 for 45 min at 37°C. BMDCs were washed twice in serum-free
HBSS and incubated in 100 g/ml gentamicin for 20 min at 37°C. Cells were then
washed and resuspended in 500 l 0.1% Triton X-100 in phosphate-buffered
saline. Ten microliters of lysates was plated onto either LB agar plates containing
ampicillin (DH5), LB agar plates containing chloramphenicol (K-12), or
Pseudomonas isolation agar plates (PA14) and incubated overnight at 37°C.
Subsequently, colonies were counted, and CFU were calculated based on the
fraction of the total sample plated.
In vivo bacterial uptake assay. A total of 5  106 live bacteria (of the strains
indicated) were injected i.p. into the indicated genotypes of mice. Mice were
sacrificed 1 h postinjection, and peritoneal lavage samples were collected. Peri-
toneal cells were pelleted, washed twice in serum-free HBSS, and resuspended in
750 l of HBSS. Five hundred microliters of each suspension was incubated in
the presence of gentamicin for 20 min at 37°C to kill noninternalized bacteria.
Cells were washed twice in serum-free HBSS and resuspended in 500 l 0.1%
Triton X-100 in phosphate-buffered saline. Fifteen microliters of resuspended
cells/bacteria was plated onto LB agar-ampicillin plates and incubated overnight
at 37°C. Colonies were counted the following morning, and CFU were calculated
based on the fraction of total sample plated.
Peritoneal cell analysis. For all in vivo phagocytosis studies, analyses of total
cell numbers and peritoneal macrophage numbers were done in parallel. Total
cell numbers harvested from peritoneal lavage samples were quantified using
trypan blue staining and manual cell counts of viable cells using a hemacytom-
eter. Macrophage numbers were assessed by fluorescence-activated cell sorter
analysis of F4/80 staining of lavage samples. Total macrophage numbers were
calculated based on the percentage of the total population that stained as F4/80
positive.
Lethal challenge experiments. Mice were lethally challenged by i.p. injection
of either 400 g of LPS, 1 109 live E. coli (DH5 or K-12), or 1 106 live PA14
bacteria. In these experiments, the results of which are shown in Fig. 6, mice were
challenged with 2  109 live DH5 E. coli bacteria. Mice were monitored
periodically, and upon loss of sternal recumbency for more than 10 s, they were
deemed terminal and euthanized.
Data and statistical analyses. Sample sizes for each experiment varied and are
noted in the text. For all graphs, mean and standard deviation are shown. As
indicated, one-way analysis of variance with Tukey’s multiple comparison post-
hoc test, unpaired Student’s t test, or Kaplan-Meier analysis was performed to
assess the statistical significance of the data. In the figures, statistical significance
is represented by an asterisk and indicates P  0.05.
RESULTS
SRA/ BMDCs produce elevated cytokines in vitro to
DH5 bacteria. We have previously identified that double
heterozygous SRA/ TLR4/ BMDCs, but not the respec-
tive single heterozygotes, are significantly impaired for uptake
of DH5 bacteria in vitro and in vivo (2). Since SRA deficiency
is reported to cause increased proinflammatory cytokine pro-
duction to purified LPS in vitro and in vivo (4, 8), we tested the
cytokine responses in our single and double heterozygous
BMDCs in response to live gram-negative bacteria. BMDCs
were cocultured with DH5 bacteria for 6 h, and supernatants
were analyzed for TNF- and IL-6 production. Consistent with
previous reports, SRA-deficient BMDCs produced increased
levels of TNF- and IL-6 in response to the bacteria (Fig. 1).
This cytokine increase was absent in SRA/ TLR4/ cells,
confirming that this phenotype is TLR4 dependent (Fig. 1).
FIG. 1. SRA/ BMDCs exhibit elevated cytokine production in response to E. coli DH5. A total of 5 105 WT, SRA/, TLR4/, SRA/
TLR4/, SRA/, or SRA/ TLR4/ BMDCs were cocultured with 5  105 DH5 bacteria for 6 hours. Cell supernatants were collected and
analyzed by ELISA for TNF- (A) or IL-6 (B) production. n 6 for all genotypes; means and standard deviations are shown. Statistical significance
(P  0.05) for values higher than WT (*) and lower than WT (**) is indicated.
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Double heterozygous SRA/ TLR4/ BMDCs showed a
cytokine profile similar to that of SRA/ cells (Fig. 1), which
parallels the observation that both genotypes are impaired for
phagocytic uptake of DH5 bacteria (2). Surprisingly, even
though SRA/ BMDCs exhibit WT levels of bacterial phago-
cytosis (2, 3), we found that these cells produce increased levels
of cytokines in response to bacteria, similar to the enhanced
cytokine levels seen in SRA/ TLR4/ and SRA/ cells
(Fig. 1). This observation is the first inflammatory cytokine
defect to be characterized for SRA/ cells and, importantly,
is the first report of a functional dichotomy between SRA-
mediated phagocytosis of bacteria and inflammatory cytokine
responses.
Bacteria independent for SRA-mediated phagocytosis elicit
elevated cytokines in an SRA-dependent manner. The depen-
dence upon SRA for bacterial phagocytosis varies widely
among bacterial species and strains (14). We exploited this
phenomenon by utilizing gram-negative bacterial strains
with various SRA phagocytic dependencies to test whether
this dictates their ability to elicit cytokines in WT and SRA-
deficient BMDCs. We observed the expected deficiency (3)
for uptake of DH5 E. coli by SRA/ cells (Fig. 2A).
However, phagocytosis of both the K-12 E. coli strain and
the PA14 P. aeruginosa strain was independent of SRA (Fig.
1A). While a minimal role for SRA in phagocytosis of K-12
E. coli has previously been reported (14), this is the first
assessment of the contribution of SRA for any P. aeruginosa
strain. WT, SRA/, and SRA/ BMDCs were stimulated
for 6 hours with the different bacterial strains or LPS and
then analyzed for TNF- (Fig. 2B) and IL-6 (Fig. 2C) pro-
duction. Despite the varied dependence of the different
bacterial strains for SRA-mediated phagocytosis, all strains
stimulated increased cytokine production in SRA/ and
SRA/ BMDCs, which concurred with the effect of LPS
stimulation (Fig. 2B and C). These data demonstrate that
enhanced cytokine responses in the absence of SRA are
independent of SRA phagocytic function.
Differential SRA-dependent phagocytosis in vivo. In order
to test the in vivo relevance of our findings, we assessed
phagocytic uptake of the different bacteria by peritoneal
cells in mice. One hour following injection of live bacteria,
peritoneal cells were harvested and treated in a gentamicin
protection assay to assess relative bacterial uptake levels.
SRA/ mice exhibited no deficit for the in vivo uptake of
DH5 E. coli, while SRA/ mice displayed a significant
defect in this regard (Fig. 3A) (2). In corroboration with our
in vitro results, SRA/ animals showed no impairment for
the in vivo uptake of either K-12 (Fig. 3B) or PA14 (Fig.
3C). This is the first demonstration of the relative SRA
dependence in vivo for the phagocytosis of different gram-
negative bacterial strains and allowed us to subsequently
test the relationship between phagocytosis and cytokine elic-
itation in vivo. To confirm that the different experimental
conditions resulted in similar numbers of peritoneal phago-
cytes, the total cells harvested for each genotype and con-
dition were quantified; no significant differences among the
groups were observed (Fig. 3D, left panel). Additionally, the
peritoneal cell isolates were stained for F4/80 to assess
the quantity of macrophages present in each sample. No
significant differences for macrophage numbers were ob-
served among the experimental groups (Fig. 3D, right
panel).
SRA/mice produce increased TNF- in vivo to both SRA-
dependent and -independent bacteria. In order to assess the in
vivo relationship between SRA-dependent bacterial phagocy-
tosis and cytokine production, we tested in vivo cytokine pro-
FIG. 2. SRA-independent gram-negative bacteria elicit in-
creased cytokines in vitro in the absence of SRA. (A) WT and
SRA/ BMDCs were assessed for relative phagocytosis of E. coli
DH5 and K-12 and P. aeruginosa PA14 bacteria by gentamicin
protection assay. Data are normalized as the percentage CFU of
WT bacterial uptake. n  9 for all groups. (B and C) A total of 5 
105 WT, SRA/, or SRA/ BMDCs were cocultured with 5  105
CFU of the indicated bacteria, or LPS as a positive control, for 6
hours. Supernatants from these cultures were collected and ana-
lyzed by ELISA for TNF- (B) and IL-6 (C). n  9; means and
standard deviations are shown. Statistical significance (P  0.05)
from WT values is indicated (*).
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duction in response to both SRA-dependent and SRA-inde-
pendent bacteria. WT or SRA/ mice were injected i.p. with
the indicated bacteria, and serum and peritoneal lavage sam-
ples were collected and analyzed for TNF- production (Fig.
4). SRA/ mice showed significant elevation in both serum
and peritoneal TNF- levels compared to WT mice in re-
sponse to DH5 (Fig. 4A), K-12 (Fig. 4B), and PA14 (Fig. 4C)
bacteria. Thus, in response to in vivo gram-negative bacterial
infection, increased cytokine production by SRA-deficient an-
imals is independent of SRA-mediated phagocytic clearance of
bacteria.
SRA-independent bacteria elicit increased susceptibility to
endotoxic shock in SRA-deficient mice. To examine whether
the increased susceptibility to endotoxic shock in SRA/ mice
is dependent upon the loss of SRA-mediated phagocytosis of
bacteria, we challenged WT and SRA/ mice with the various
bacterial strains. As a positive control, SRA-deficient mice
challenged i.p. with LPS showed the expected increase in le-
thality (Fig. 5A). Lethal challenge studies with DH5 (Fig.
5B), K-12 (Fig. 5C), and PA14 (Fig. 5D) bacteria showed that
SRA/ mice were more susceptible than WT mice to endo-
toxic shock for all the bacteria tested. These are the first re-
ports of endotoxic shock studies of SRA/ mice using either
E. coli or P. aeruginosa bacterial challenge models. Impor-
tantly, these data formally demonstrate that SRA-mediated
resistance to endotoxin in vivo is functionally independent
from SRA-mediated phagocytosis of bacteria.
Lethal endotoxic shock in SRA-deficient mice is dependent
on TLR4 and MyD88. To demonstrate that the gram-negative
bacterial toxicity in SRA-deficient animals is mediated by
increased proinflammatory signaling induced by LPS, we
injected WT, SRA/ TLR4/ double knockout, and
MyD88/ knockout mice with a high-dose DH5 challenge.
At a dose (1  109 CFU) that was fully lethal for WT animals,
SRA/ TLR4/ and MyD88/ knockout mice were com-
pletely protected from the toxic effects of this challenge (Fig.
6). These results provide formal in vivo evidence that lethality
to gram-negative bacterial challenge is mediated by proinflam-
matory signaling of the TLR4/MyD88-dependent signaling
axis. These data strongly support a model where, even in the
context of infection by bacteria that are not recognized by SRA
during phagocytic clearance, SRA still provides a critical role
FIG. 3. SRA dependence for phagocytosis varies among different bacterial strains in vivo. (A) WT, SRA/, or SRA/ mice were injected i.p.
with 5  106 live DH5 E. coli cells. Peritoneal phagocytes were subsequently harvested by lavage, and relative phagocytosis was assessed by
gentamicin protection assay. SRA/ mice were found to be significantly impaired in phagocytosis of DH5 (P  0.01) from both WT and
SRA/mice. (B and C) No statistically significant difference was observed between WT and SRA/ mice injected with 5  106 live K-12 E. coli
(B) or PA14 P. aeruginosa (C) bacteria. (D) Total cell harvests from peritoneal lavage samples and total macrophage numbers were quantified.
No statistical differences among the groups were found. For phagocytosis assays, data are normalized as the percentage CFU of WT bacterial
uptake. n  8 for all groups. The mean and individual mouse values are represented on the graphs. Statistical significance (P  0.05) from
WT values is indicated (**).
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in modulation of the host inflammatory response and endo-
toxic shock.
DISCUSSION
During infection by gram-negative bacteria, the immune re-
sponse is challenged with the task of eliminating the bacteria as
well as inflammatory bacterial products, like LPS, that are shed
into the extracellular space (12). When gram-negative bacterial
infections remain unresolved in the infected host, these infec-
tions can result in lethal hyperinflammatory responses known
as endotoxic shock (8). Resistance to endotoxic shock is criti-
cally regulated by the ability of the infected organism to elim-
inate endotoxin and thereby limit the proinflammatory stimu-
lation elicited by this molecule. Because SRA is uniquely
involved in both phagocytic bacterial clearance and modula-
tion of inflammation via endocytic scavenging of soluble LPS,
it is a key molecule in controlling the inflammatory response to
endotoxin and infection by gram-negative bacteria. However,
the relationship between bacterial phagocytosis and LPS clear-
ance by SRA has not previously been defined.
In this report, we used two alternative and complementary
approaches to demonstrate a functional dichotomy between
SRA-mediated phagocytosis of bacteria and the associated
LPS-driven inflammatory response. First, we utilized a ge-
netic approach to show that SRA/ cells exhibit increased
cytokine responses to gram-negative bacteria in the absence
of a phagocytic defect in these cells. These data are the first
report of an inflammatory defect in cells heterozygous for
SRA and underscore the importance of SRA-mediated en-
dotoxin clearance in dampening the inflammatory response
to gram-negative bacteria. Additionally, by using gram-neg-
ative bacteria that have no SRA dependence for their
phagocytic uptake, we show that these bacteria still elicit
hyperinflammation in vitro and in vivo and enhanced toxic
shock in the context of SRA deficiency. This uncoupling of
SRA-mediated phagocytic clearance of bacteria from SRA-
dependent regulation of inflammatory signaling demon-
strates a highly important immune function for SRA even in
the context of bacterial infection by microbes that can evade
phagocytic recognition by this receptor.
SRA has been well characterized for its ability to bind and
clear soluble LPS via recognition of the lipid A moiety of
endotoxin (7). Until recently, SRA-mediated recognition of
LPS has been presumed to be a mechanism by which SRA
recognizes and mediates phagocytic uptake of gram-negative
bacteria. However, recently published work using Neisseria
meningitidis has shown that SRA recognizes this particular
gram-negative bacterium in an endotoxin-independent manner
(13, 15). In conjunction with these studies, our data challenge
the notion that LPS recognition by SRA is critically involved in
the phagocytic function of SRA for gram-negative bacteria.
Our findings that SRA can regulate proinflammatory cytokine
production irrespective of its role in bacterial phagocytosis are
consistent with a model in which LPS and the bacterial phago-
cytic ligands may possibly bind to distinct sites of the SRA
receptor. From a teleological perspective, this model provides
an intriguing mechanistic interpretation of how endocytic and
phagocytic functions of SRA can function simultaneously with-
out compromising either phagocytic clearance of infecting bac-
teria or the regulation of the inflammatory response to infec-
tion.
Heretofore, increased susceptibility to endotoxic shock and
infection in SRA/ mice has been described only for gram-
negative bacteria that are phagocytosed in an SRA-dependent
manner (8, 10, 16, 18). Under endotoxic shock conditions,
SRA limits TLR4-driven proinflammatory cytokine responses
by clearing LPS from the extracellular environment (8). This
phenomenon was previously thought to be intrinsically related
to decreased phagocytic clearance of bacteria in the absence of
SRA. We have utilized in vitro and in vivo models to demon-
strate that SRA-mediated endocytosis of LPS is independent
of phagocytic uptake of bacteria during gram-negative bacte-
rial infection. These data provide a novel understanding of the
role of SRA in limiting the inflammatory responses to endo-
FIG. 4. SRA/ mice produce increased cytokines in vivo to
both SRA-dependent and -independent bacteria. WT and SRA/
mice were injected i.p. with 1  109 live DH5 bacteria (A), 1  109
live K-12 bacteria (B), or 5  107 live PA14 bacteria (C). After 3
hours, serum and peritoneal lavage samples were collected and
analyzed by ELISA for TNF- levels. n  4; means and standard
deviations are shown. Statistical significance (P  0.05) from WT
values is indicated (*).
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toxin. Furthermore, these data illustrate for the first time that
SRA utilizes two distinct and independent trafficking pathways
to mediate innate immune responses during infection by gram-
negative bacteria.
ACKNOWLEDGMENTS
This research was supported by National Institutes of Health (NIH)
grants COBRE P20RR016437 and R01 AI067405, a Dartmouth DC-
CTS Pilot Grant, a Cystic Fibrosis Foundation-RDP grant (B.B.), and
NIH Training Grant T32 AI07363 (E.A.).
We thank Kevin Hart, George O’Toole, and Deb Hogan (Dart-
mouth) for their help and advice.
REFERENCES
1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami,
K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene
results in loss of IL-1- and IL-18-mediated function. Immunity 9:143–150.
2. Amiel, E., A. Alonso, S. Uematsu, S. Akira, M. E. Poynter, and B. Berwin.
2009. Pivotal advance: Toll-like receptor regulation of scavenger receptor-
A-mediated phagocytosis. J. Leukoc. Biol. 85:595–605.
3. Amiel, E., S. Nicholson-Dykstra, J. J. Walters, H. Higgs, and B. Berwin.
2007. Scavenger receptor-A functions in phagocytosis of E. coli by bone
marrow dendritic cells. Exp. Cell Res. 313:1438–1448.
4. Becker, M., A. Cotena, S. Gordon, and N. Platt. 2006. Expression of the class
A macrophage scavenger receptor on specific subpopulations of murine
dendritic cells limits their endotoxin response. Eur. J. Immunol. 36:950–960.
5. Duncan, M. J., G. Li, J. S. Shin, J. L. Carson, and S. N. Abraham. 2004.
FIG. 5. SRA/ mice are more susceptible to lethal endotoxic shock induced by both SRA-dependent and -independent bacteria. (A) As a
positive control, WT and SRA/ mice were challenged i.p. with 400 g LPS. (B to D) Survival plots of WT and SRA/ mice challenged i.p. with
1  109 CFU live DH5 bacteria (B), 1  109 CFU live K-12 bacteria (C), or 1  106 CFU live PA14 bacteria (D). For all graphs, n  9. Under
every condition, SRA/ mice were found to be significantly more susceptible to the indicated challenge than WT mice. Statistical significance
(P  0.05) from WT values is indicated (*).
FIG. 6. High-dose bacterial challenge-induced lethality is depen-
dent on TLR4 and MyD88 expression. Survival plot of WT, SRA/
TLR4/, and MyD88/ mice challenged i.p. with 2  109 CFU
live DH5 bacteria. At lethal doses for WT animals, SRA/
TLR4/ and MyD88/ mice were completely resistant to endo-
toxic shock. n  4. Statistical significance (P  0.05) from WT
values is indicated (*).
4572 AMIEL ET AL. INFECT. IMMUN.
Bacterial penetration of bladder epithelium through lipid rafts. J. Biol.
Chem. 279:18944–18951.
6. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994.
The type I macrophage scavenger receptor binds to gram-positive bacteria
and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91:1863–1867.
7. Hampton, R. Y., D. T. Golenbock, M. Penman, M. Krieger, and C. R. Raetz.
1991. Recognition and plasma clearance of endotoxin by scavenger recep-
tors. Nature 352:342–344.
8. Haworth, R., N. Platt, S. Keshav, D. Hughes, E. Darley, H. Suzuki, Y.
Kurihara, T. Kodama, and S. Gordon. 1997. The macrophage scavenger
receptor type A is expressed by activated macrophages and protects the host
against lethal endotoxic shock. J. Exp. Med. 186:1431–1439.
9. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S.
Muramatsu, and R. M. Steinman. 1993. Granulocytes, macrophages, and
dendritic cells arise from a common major histocompatibility complex class
II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA
90:3038–3042.
10. Ishiguro, T., M. Naito, T. Yamamoto, G. Hasegawa, F. Gejyo, M. Mitsuyama,
H. Suzuki, and T. Kodama. 2001. Role of macrophage scavenger receptors
in response to Listeria monocytogenes infection in mice. Am. J. Pathol.
158:179–188.
11. Kunjathoor, V. V., M. Febbraio, E. A. Podrez, K. J. Moore, L. Andersson, S.
Koehn, J. S. Rhee, R. Silverstein, H. F. Hoff, and M. W. Freeman. 2002.
Scavenger receptors class A-I/II and CD36 are the principal receptors re-
sponsible for the uptake of modified low density lipoprotein leading to lipid
loading in macrophages. J. Biol. Chem. 277:49982–49988.
12. Mattsby-Baltzer, I., K. Lindgren, B. Lindholm, and L. Edebo. 1991. Endo-
toxin shedding by enterobacteria: free and cell-bound endotoxin differ in
Limulus activity. Infect. Immun. 59:689–695.
13. Peiser, L., M. P. De Winther, K. Makepeace, M. Hollinshead, P. Coull, J.
Plested, T. Kodama, E. R. Moxon, and S. Gordon. 2002. The class A mac-
rophage scavenger receptor is a major pattern recognition receptor for
Neisseria meningitidis which is independent of lipopolysaccharide and not
required for secretory responses. Infect. Immun. 70:5346–5354.
14. Peiser, L., P. J. Gough, T. Kodama, and S. Gordon. 2000. Macrophage class
A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell
heterogeneity, microbial strain, and culture conditions in vitro. Infect. Im-
mun. 68:1953–1963.
15. Peiser, L., K. Makepeace, A. Pluddemann, S. Savino, J. C. Wright, M. Pizza,
R. Rappuoli, E. R. Moxon, and S. Gordon. 2006. Identification of Neisseria
meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger
receptor by using a novel assay. Infect. Immun. 74:5191–5199.
16. Plu¨ddemann, A., J. C. Hoe, K. Makepeace, E. R. Moxon, and S. Gordon.
2009. The macrophage scavenger receptor a is host-protective in experimen-
tal meningococcal septicaemia. PLoS Pathog. 5:e1000297.
17. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, H.
Sakaguchi, J. K. Kruijt, T. Higashi, T. Suzuki, T. J. van Berkel, S. Horiuchi,
K. Takahashi, Y. Yazaki, and T. Kodama. 1997. The multiple roles of
macrophage scavenger receptors (MSR) in vivo: resistance to atherosclerosis
and susceptibility to infection in MSR knockout mice. J. Atheroscler.
Thromb. 4:1–11.
18. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O.
Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, Y. Takashima, Y. Kawabe, O.
Cynshi, Y. Wada, M. Honda, H. Kurihara, H. Aburatani, T. Doi, A. Matsu-
moto, S. Azuma, T. Noda, Y. Toyoda, H. Itakura, Y. Yazaki, T. Kodama, et
al. 1997. A role for macrophage scavenger receptors in atherosclerosis and
susceptibility to infection. Nature 386:292–296.
19. Thomas, C. A., Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El
Khoury. 2000. Protection from lethal gram-positive infection by macrophage
scavenger receptor-dependent phagocytosis. J. Exp. Med. 191:147–156.
20. Van Lenten, B. J., A. M. Fogelman, J. Seager, E. Ribi, M. E. Haberland, and
P. A. Edwards. 1985. Bacterial endotoxin selectively prevents the expression
of scavenger-receptor activity on human monocyte-macrophages. J. Immu-
nol. 134:3718–3721.
Editor: A. Camilli
VOL. 77, 2009 SEGREGATION OF SRA PHAGOCYTOSIS AND INFLAMMATION 4573
